MAPT and drug-induced dyskinesia: While neurological signs associated with PSP, such as dyskinesia (1.01E‐15) and cognitive impairment (2.06E‐3) (Figure 3), also indicated enrichment of proteins known to associate with Tau and with involvement in neurological dysfunction.